What are the opening hours?

Monday 9am - 3pm Tuesday 9am - 3pm Wednesday 9am - 3pm Thursday 9am - 3pm Friday 9am - 3pm

Framingham Heart Study

Home
United States
Framingham, MA
Framingham Heart Study

The Framingham Heart Study (FHS) is one of the world’s most informative and longest-running studies

The Framingham Heart Study (FHS) is one of the world's most regarded research studies, starting first with its work on heart disease and expanding to other chronic diseases such as stroke, cancer, osteoporosis, diabetes and Alzheimer's disease. With over 4,000 articles published in academic journals such as the New England Journal of Medicine, the Journal of the American Medical Association, Nature Genetics, Circulation and the Lancet, FHS now seeks to do more. Fueled by the extraordinary dedication of three generations of participants, Framingham’s expansion into genomics, transcriptomics, and proteomics coupled with on-going integration of state-of-the-art technology, reflects its continued pursuit of new and innovative research. FHS is credited with much of the earliest findings that smoking, high blood pressure, high cholesterol, obesity, and diabetes lead to heart disease. In coining the term "risk factor" in 1961, the study set the foundation for the field of preventive medicine. Today, the study remains a global epicenter for public health research, operating at the intersection of population research, omics, systems biology, and personalized medicine. The Framingham Heart Study is supported by the National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health and Boston University School of Medicine, under NIH award 75N92019D00031.

11/24/2025

We have officially launched our first Framingham Heart Study Podcast YouTube video!

In today’s episode we are joined by Dr. Gopal and Fetterman as they explain the LEGACY program and their involvement in the upcoming exam!

Link ⬇️

https://m.youtube.com/watch?v=IyZvAn4MN-w

11/11/2025

On this Veterans Day, the Framingham Heart Study proudly recognizes and extends our deepest gratitude to all who have served in the United States Armed Forces. We honor your courage, commitment, and sacrifice in service to our nation.

10/31/2025

Happy Halloween from your friends at The Framingham Heart Study!

10/21/2025

Thank you to everyone who joined us in celebrating the 325th anniversary Framingham!

09/17/2025

The Framingham Heart Study will be attending Framingham Fest!

Details in post.

We can’t wait to see you there!

07/16/2025

What if I told you high blood pressure was one of the biggest risk factors for Stroke?

Findings from the Framingham Heart Study from 1970 help explain the correlation.

05/30/2025

Does lower muscle mass lead to greater injury risk? Well let’s see if we can answer that question!

05/28/2025

Today we breakdown glucose and continuous glucose monitors. Explaining some of the recent findings and information uncovered by the Framingham Heart Study

Address

73 Mount Wayte Avenue Ste 2
Framingham, MA
01702

Opening Hours

Monday	9am - 3pm
Tuesday	9am - 3pm
Wednesday	9am - 3pm
Thursday	9am - 3pm
Friday	9am - 3pm

Telephone

+15088726562

Website

http://www.framinghamheartstudy.org/

Alerts

Be the first to know and let us send you an email when Framingham Heart Study posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Framingham Heart Study:

Want your practice to be the top-listed Clinic in Framingham?

Our Story

The Framingham Heart Study (FHS) is one of the world's most regarded research studies, starting first with its work on heart disease and expanding to other chronic diseases such as stroke, cancer, osteoporosis, diabetes and Alzheimer's disease. With over 3,700 articles published in academic journals such as the New England Journal of Medicine, the Journal of the American Medical Association, Nature Genetics, Circulation and the Lancet, FHS now seeks to do more. Fueled by the extraordinary dedication of three generations of participants, Framingham’s expansion into genomics, transcriptomics, and proteomics coupled with on-going integration of state-of-the-art technology, reflects its continued pursuit of new and innovative research. Framingham is credited with much of the earliest findings that smoking, high blood pressure, high cholesterol, obesity, and diabetes lead to heart disease. In coining the term "risk factor" in 1961, the study set the foundation for the field of preventive medicine. Today, the study remains a global epicenter for public health research, operating at the intersection of population research, omics, systems biology, and personalized medicine. The Framingham Heart Study is a project of Boston University and the National Heart Lung and Blood Institute.

The Framingham Heart Study is supported by the National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health and Boston University School of Medicine, under NIH award 75N92019D00031.